Literature DB >> 34622765

Flare-up of adult-onset Still's disease after receiving a second dose of BNT162b2 COVID-19 mRNA vaccine.

Shintaro Yamamoto1, Keisuke Nishimura2, Kohei Yo1, Daisuke Waki1, Hiroyuki Murabe1, Toshihiko Yokota1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34622765     DOI： 10.55563/clinexprheumatol/tvlpnc

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN： 0392-856X            Impact factor:   4.473


× No keyword cloud information.
  6 in total

Review 1.  Hyperinflammation after anti-SARS-CoV-2 mRNA/DNA vaccines successfully treated with anakinra: Case series and literature review.

Authors:  Sara Bindoli; Alessandro Giollo; Paola Galozzi; Andrea Doria; Paolo Sfriso
Journal:  Exp Biol Med (Maywood)       Date:  2022-01-22

2.  Adult-onset Still's Disease after BNT162b2 mRNA COVID-19 Vaccine.

Authors:  Seong Yeon Park; Kwang-Hoon Lee
Journal:  J Korean Med Sci       Date:  2021-12-27       Impact factor: 2.153

Review 3.  Two flares of Still's disease after two doses of the ChAdOx1 vaccine.

Authors:  Rashmi Roongta; Sumantro Mondal; Subhankar Haldar; Mavidi Sunil Kumar; Alakendu Ghosh
Journal:  Clin Rheumatol       Date:  2022-03-06       Impact factor: 3.650

Review 4.  Autoimmune and autoinflammatory conditions after COVID-19 vaccination. New case reports and updated literature review.

Authors:  Yhojan Rodríguez; Manuel Rojas; Santiago Beltrán; Fernando Polo; Laura Camacho-Domínguez; Samuel David Morales; M Eric Gershwin; Juan-Manuel Anaya
Journal:  J Autoimmun       Date:  2022-08-24       Impact factor: 14.511

5.  Successful Treatment of SARS-CoV-2 Vaccination-related Activation of Rheumatoid Arthritis with Positive Findings for Epstein-Barr Virus.

Authors:  Hideki Nakamura; Yosuke Nagasawa; Hitomi Kobayashi; Masako Tsukamoto; Tadateru Takayama; Noboru Kitamura
Journal:  Intern Med       Date:  2022-04-23       Impact factor: 1.282

6.  Reactivation of adult-onset Still's disease after use of the COVID-19 ChAdOx1-S vaccine.

Authors:  Sebastián E Ibáñez Vodnizza; Luis Morales Murillo; Matías de la Rivera Vergara; Roberto Saldías Martínez
Journal:  BMJ Case Rep       Date:  2022-08-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.